Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective StudyDavide Fiore Bavaro, Annalisa Saracino, Michele Camporeale et al.|Viruses|2023Cited by 13
Oral anti‐viral therapy for early <scp>COVID</scp>‐19 infection in patients with haematological malignancies: A multicentre prospective cohortCarla Minoia, Davide Fiore Bavaro, Lucia Diella et al.|British Journal of Haematology|2023Cited by 11
Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung FailureCarla Minoia, Annalisa Saracino, Davide Fiore Bavaro et al.|Blood|2022Cited by 0